ELTROMBOPAG DOSING REGIMEN

The present invention relates to a method of treating immune thrombocytopenia (ITP) by administering eltrombopag or a pharmaceutically acceptable salt thereof to a patient.

Saved in:
Bibliographic Details
Main Authors COOPER, Nichola, STANKOVIC, Miona, ZAJA, Francesco, GHANIMA, Waleed
Format Patent
LanguageEnglish
Published 06.10.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method of treating immune thrombocytopenia (ITP) by administering eltrombopag or a pharmaceutically acceptable salt thereof to a patient.
Bibliography:Application Number: US201917611012